Taro Pharmaceutical (TARO) Won't Comment on Unusual Stock Activity
Tweet Send to a Friend
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced that in view of the unusual market activity in the Company’s stock, the New York Stock Exchange has contacted the Company in accordance with its usual practice. The NYSE has asked the Company to respond by press release to the unusual activity.
The Company’s policy is not to comment on unusual market activity, rumors or speculation.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Company’s policy is not to comment on unusual market activity, rumors or speculation.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Kodak (EKDKQ) Asks Court to Approve $406M Rights Offering on Bankruptcy Emergence
- Rambus (RMBS) Enters License with STMicro (STM)
- TransDigm (TDG) Considers $1-$1.8B Special Dividend; Requests to Amend Credit Facility
Create E-mail Alert Related Categories
Corporate News
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
